NovoCure GmbH

Clinical trials sponsored by NovoCure GmbH, explained in plain language.

NovoCure GmbH NVCR NASDAQ

A medical device company developing tumor-treating electric fields for cancer therapy.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Trials to join now! 2 Not yet finished but already full! 1 Completed 2 Terminated 1

Zapping tumors: electric fields tested against pancreatic cancer

Disease control Expanded access (paused)

This program gives adults with locally advanced pancreatic cancer access to a device that delivers gentle electric fields to the abdomen, combined with standard chemotherapy. The goal is to see if this approach is safe and feasible while the device awaits FDA approval. Participan…

Sponsor: NovoCure GmbH • Aim: Disease control

Last updated Jun 27, 2026 08:09 UTC

NovoCure GmbH

Zapping tumors: electric fields tested against pancreatic cancer